
Sign up to save your podcasts
Or


#835B: Dr Sharon L. Campbell, DVM, MS, DACVIM, is the Medical Affairs Lead on Canine Chronic Pain at Zoetis, where they have developed Librela, a once-monthly injectable monoclonal antibody treatment for the control of canine osteoarthritis, since 40% of dogs of ALL ages have signs of OA.
By Tracie Hotchner3.9
1717 ratings
#835B: Dr Sharon L. Campbell, DVM, MS, DACVIM, is the Medical Affairs Lead on Canine Chronic Pain at Zoetis, where they have developed Librela, a once-monthly injectable monoclonal antibody treatment for the control of canine osteoarthritis, since 40% of dogs of ALL ages have signs of OA.

91,134 Listeners

1,722 Listeners

4,356 Listeners

42 Listeners

7,736 Listeners

9 Listeners

13,257 Listeners

3 Listeners

3 Listeners

112,597 Listeners

14,311 Listeners

4,489 Listeners

89 Listeners

40,451 Listeners

10,452 Listeners

708 Listeners

1,664 Listeners

2,878 Listeners

5 Listeners